Brief medicine trial to help reduce heavy alcohol drinking
Part of Mental health clinical trials.
This Phase 2 study tests a brief medication approach meant to reduce “problem drinking.” It may help people cut back or stop alcohol use by adjusting brain signaling related to drinking cravings and urges.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You currently have an alcohol use disorder and you’ve had heavy drinking most days recently
- You’re generally physically healthy enough for study participation
- You can safely stay away from alcohol for the first 24 hours of the study
- You’re age 21 to 70 and can understand and follow study instructions (English)
- You don’t have certain mental health conditions like major depression, bipolar disorder, or schizophrenia
- You don’t have serious safety issues (heart problems, uncontrolled medical illnesses, pregnancy)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new medication called NTX-2001 can help people with alcohol use disorder drink less. Researchers will measure how the drug affects alcohol consumption and safety in adults aged 21–60.
This study tests a new way to quickly screen medications for alcohol use disorder (AUD). You will have lab sessions where your drinking is monitored to see how different medicines affect your alcohol use.
This early-phase study looks at how the brain’s opioid receptor balance may be different in people with alcohol use disorder (AUD), using brain scans and blood testing. It may help researchers understand why some people respond differently to alcohol and related treatments.
This study tests whether the medication nimodipine (usually used for blood pressure) can help people who drink heavily reduce how much they drink. If you join, you may receive the medication or a placebo (a pill with no active ingredient) and take part in drinking sessions to see how it affects you.
This study tests if a blood-pressure medicine called nimodipine can help people who drink heavily reduce their alcohol intake. The trial involves lab-based drinking sessions and brain scans to understand how the drug works on the brain.
This study is looking at ways to increase “alcohol abstinence,” meaning drinking less or stopping. It focuses on young adults who currently drink and have symptoms of alcohol use disorder, and it may help them build skills to reduce or stop drinking.
Hear when a new Alcohol Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.